Development and External Validation of an Endoscopic and Histologic Pouchitis Assessment Tool: The Atlantic Pouchitis Index
Rocío Sedaño, Vipul Jairath(Western University), Julie Rémillard, Bruce E. Sands(Icahn School of Medicine at Mount Sinai), Bozidar Bojić(Psychiatry Baselland), Iris Dotan(Tel Aviv University), Lisa M. Shackelton, Mark Samaan(New Leaders), Ailsa Hart(St Mark's Hospital), Christopher Ma(University of Calgary), Brian G. Feagan(Western University), Geert D’Haens(Amsterdam University Medical Centers), Roger Feakins(Royal Free London NHS Foundation Trust), Brian Bressler(University of British Columbia), Guangyong Zou(Western University), Richard Kirsch(University of Toronto), Malcolm Hogan, Stefanie C. McFarlane, Gregory Rosenfeld(University of British Columbia), Aude Marchal(Centre hospitalier Emile Roux), Mark S. Silverberg(Sinai Health System), Simon Travis(University of Oxford), Remo Panaccione(University of Calgary)
Cited by 3
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k